This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Insiders Are Scooping Up

CVS Caremark

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

A stock in the retail drug complex whos insiders are buying up a large amount of stock in is CVS Caremark (CVS - Get Report), a pharmacy healthcare provider in the U.S. Insiders are buying into some mild strength here since this stock is up over 9.4% in 2012.

CVS Caremark has a market cap of $57 billion and an enterprise value of $66 billion. This stocks trades at a cheap valuation, with a trailing price-to-earnings of 17 and a forward price-to-earnings of 12. Its estimated growth rate for this year is 16.8%, and for next year it's pegged at 12.5%. This is not a cash-rich company, since the total cash position on its balance sheet is $1.42 billion and its total debt is a whopping $10.01 billion.

A vice president just bought 46,400 shares, or about $1.99 million worth of stock, at $42.99 per share.

From a technical perspective, CVS is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock broke out above $39.15 to $39.26 a share a few months ago on huge volume. Since triggering that breakout, this stock has uptrended strong towards its current price of $44.50 a share.

If you're a bullish on CVS, then I would look for long biased trades as long as this stock is trending above $44 a share, and the upside volume is tracking in strong. If this stock were to trade back below $44, then I would look for long setups near the 200-day moving average of $42.97 or the 50-day moving average of $41.36 a share. I would avoid any long trades in CVS if the 50-day and 200-day were violated with big volume.

CVS, one of Warren Buffett's holdings, shows up on lists of 8 UBS Stock Picks for 2012 and 3 Health Care Buys for 2012.

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
NYX $0.00 0.00%
CVS $103.53 2.10%
FSYS $5.23 -0.76%
HALO $9.98 -8.00%
TWO $7.65 -1.70%


Chart of I:DJI
DOW 17,662.84 -88.07 -0.50%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs